The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Can Lupus Be Prevented? Research Reveals Clues to Who’s Most Likely to Transition to Classified Disease

Can Lupus Be Prevented? Research Reveals Clues to Who’s Most Likely to Transition to Classified Disease

February 25, 2020 • By Susan Bernstein

  • Tweet
  • Email
Print-Friendly Version / Save PDF

In a review published in 2019, Dr. James’ laboratory collaborated with rheumatology researchers from the University of Colorado to compare elevations of soluble mediators that precede both clinical SLE and rheumatoid arthritis (RA) in patient cohorts from the U.S. military. Within one to two years before patients meet the classification criteria for RA, certain cytokines and chemokines, including IL-6, IFN-c and TNF-b, dramatically increase. In lupus, cytokines and chemokines elevate within the final year before classification, with BLyS ramping up very close to diagnosis, she said.7

You Might Also Like
  • Biomarkers, Genetic Clues to Higher Cardiovascular Disease Risk in Patients with Lupus
  • 2013 ACR/ARHP Annual Meeting: Clues to Predictors of Autoimmune Disease Revealed
  • New Study Reveals Limitations in ANA Test Kits for Lupus
Explore This Issue
March 2020
Also By This Author
  • Food for Thought: On Eating & Inflammation in Rheumatic Disease

Risk Influencers
Research teams are using very large patient cohorts, such as the Nurses’ Health Study I and II, and the Black Women’s Health Study, to identify epidemiological factors, including age at menarche, smoking status, obesity and alcohol use, that may influence lupus risk. Nurses’ Health Study data were used to show that moderate drinking is somewhat protective when it comes to lupus risk in women, and depression is associated with elevated SLE risk.8,9

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Relatives of SLE patients often ask Dr. James about their risk of developing lupus or other autoimmune diseases. She and her colleagues studied patients and first-degree relatives of people with SLE and RA in a study published in 2019.10 They examined serum samples from family members to look for disease-specific autoantibodies and tested samples for antibodies against thyroid disease, celiac disease and type-1 diabetes. The study grouped patients as having alternative autoantibodies if they had at least one autoantibody not associated with their relative’s autoimmune disease and having expanded autoimmunity if they had autoantibodies associated with two or more different diseases.

SLE patients’ relatives were more likely than RA patients’ relatives to have either alternative or expanded autoimmunity. Alternative autoimmunity was primarily systemic in the SLE cohort, while it was organ-specific in families of patients with type-1 diabetes. People in the RA cohort were more likely to have both systemic and organ-specific alternative autoimmunity, and they had mostly anti-TPO antibodies.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

In a follow-up study, Dr. James and her collaborators studied blood samples from lupus patients’ relatives to look for factors that may indicate which autoantibody-positive relatives had the highest risk of transitioning to lupus. They identified 45 relatives of lupus patients from lupus genetics studies who had transitioned to having four or more ACR SLE classification criteria during a mean follow-up period of 6.4 years; 73.8% were European American, 14.7% were African American, 2.5% were Hispanic and 9% were from other ethnic backgrounds, including Native Americans. European Americans had the lowest transition rate, 0.81 transitions per 100 follow-up years, while African Americans had 1.45 transitions and Native Americans had 2.27 transitions.11

Pages: 1 2 3 4 5 6 7 | Single Page

Filed Under: Conditions, SLE (Lupus) Tagged With: 2019 ACR/ARP Annual Meeting, environmental factor, genetic, SLE, systemic lupus erythematosus (SLE)Issue: March 2020

You Might Also Like:
  • Biomarkers, Genetic Clues to Higher Cardiovascular Disease Risk in Patients with Lupus
  • 2013 ACR/ARHP Annual Meeting: Clues to Predictors of Autoimmune Disease Revealed
  • New Study Reveals Limitations in ANA Test Kits for Lupus
  • Study Reveals Role of IL-17–Secreting CD4+ T Cells in Lupus

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2022 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.